We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$144B
AUM Growth
+$27.9B
Cap. Flow
+$22.2B
Cap. Flow %
15.4%
Top 10 Hldgs %
31.02%
Holding
7,740
New
680
Increased
3,884
Reduced
2,259
Closed
408

Sector Composition

Rank Sector Weight
1 Technology 8.24%
2 Financials 5.68%
3 Healthcare 5.62%
4 Consumer Discretionary 5.04%
5 Industrials 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRKR icon
5951
Marker Therapeutics
MRKR
$19.2M
$52K ﹤0.01%
580
-220
-28% -$18.9K
NGNE icon
5952
Neurogene
NGNE
$729M
$52K ﹤0.01%
+880
New +$51.9K
SABR icon
5953
CALL
Sabre
SABR
$835M
$52K ﹤0.01%
+2,000
New +$51.3K
SCO icon
5954
ProShares UltraShort Bloomberg Crude Oil
SCO
$598M
$52K ﹤0.01%
49
-230
-82% -$293K
UVV icon
5955
PUT
Universal Corp
UVV
$1.18B
$52K ﹤0.01%
+800
New +$51K
WNS
5956
DELISTED
WNS Holdings
WNS
$52K ﹤0.01%
1,023
-1,095
-52% -$56K
WOR icon
5957
CALL
Worthington Enterprises
WOR
$2.79B
$52K ﹤0.01%
+1,946
New +$54.7K
SCTL
5958
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$52K ﹤0.01%
8,100
+5,659
+232% +$32.1K
SC
5959
CALL
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$52K ﹤0.01%
2,600
-6,600
-72% -$135K
IDTI
5960
PUT
DELISTED
Integrated Device Technology I
IDTI
$52K ﹤0.01%
1,100
-5,400
-83% -$209K
CCT
5961
DELISTED
Corporate Capital Trust, Inc.
CCT
$52K ﹤0.01%
+3,395
New +$55.8K
AC
5962
DELISTED
Associated Capital Group
AC
$51K ﹤0.01%
1,204
+753
+167% +$28.7K
ALKS icon
5963
CALL
Alkermes
ALKS
$8.29B
$51K ﹤0.01%
1,200
-2,800
-70% -$122K
BKE icon
5964
PUT
Buckle
BKE
$2.4B
$51K ﹤0.01%
2,200
-13,200
-86% -$325K
DBI icon
5965
CALL
Designer Brands
DBI
$334M
$51K ﹤0.01%
1,500
-2,700
-64% -$78.9K
GPN icon
5966
CALL
Global Payments
GPN
$22.8B
$51K ﹤0.01%
400
+300
+300% +$36.1K
BINI
5967
DELISTED
Bollinger Innovations
BINI
0
RS icon
5968
PUT
Reliance Steel & Aluminium
RS
$21.9B
$51K ﹤0.01%
600
-4,400
-88% -$389K
SCM icon
5969
Stellus Capital Investment Corp
SCM
$245M
$51K ﹤0.01%
3,749
-221
-6% -$2.98K
ICPT
5970
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$51K ﹤0.01%
400
+100
+33% +$10.6K
PIR
5971
DELISTED
Pier 1 Imports, Inc.
PIR
$51K ﹤0.01%
1,714
-369
-18% -$14.6K
CALL
5972
DELISTED
magicJack VocalTec Ltd
CALL
$51K ﹤0.01%
6,100
CTIC
5973
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$51K ﹤0.01%
23,764
-14,906
-39% -$36.9K
FSFG
5974
DELISTED
First Savings Financial Group
FSFG
$50K ﹤0.01%
2,184
+1,785
+447% +$41.6K
IRMD icon
5975
iRadimed
IRMD
$1.15B
$50K ﹤0.01%
1,338
+237
+22% +$6.39K

Similar funds

Barclays's Q3 2018 Portfolio in Review

As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.

  • Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
  • Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
  • Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
  • Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
  • Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
  • Barclays opened 680 new positions and closed 408 in Q3 2018.
  • Barclays's portfolio value rose 24% quarter-over-quarter to $144B.

Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.